Figure 4From: Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded, superiority trial Benefits from targeted temperature management in relation to patient’s prognosis documented in previous studies and expected in the HYPERION trial. Back to article page